Open tender · Germany · Contract notice

Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Natriumphenylbutyrat, ATC A16AX03 für die Zeit 01.11.2025 - 31.10.2027

DAK-Gesundheit

DAK-Gesundheit in Germany is inviting bids for “Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Natriumphenylbutyrat, ATC A16AX03 für die Zeit 01.11.2025…”. Bids close on 5 September 2027.

The work

Non-exclusive discount agreement for the active substance Natriumphenylbutyrat (ATC A16AX03) for the period 01.11.2025 - 31.10.2027.

  • Submission of offer by the 5th of the preceding month for the desired start date

Key facts

Contract period
01.11.2025 - 31.10.2027
Evaluation
Selection based on the content of the application letter
Submission
Online, on the e-procurement portal

What it takes to qualify

Worth a closer look

  • § 130a Absatz 8 SGB V
  • Regularien des 4. Teils des GWB
  • Zulassungsmodells
  • offene Verfahren

Policy conditions

No reservation, preference or local-content restriction.

Documents to submit

  1. AngebotsschreibenSubmission of a letter of offer
  2. Anerkennung der vertraglichen MaßgabenSubmission of a signed contract acknowledging DAK terms
  3. Anlage 1 zum VertragSubmission of a completed contract attachment
  4. Anlage 2 zum VertragSubmission of a completed contract attachment in Excel format